Core Insights - Hims & Hers Health, Inc. (HIMS) reported a significant decline in earnings per share (EPS) for Q3 2025, with EPS at 6 cents, down 81.3% from 32 cents in the same period last year [1][10]. Revenue Performance - Hims & Hers achieved revenues of $598.9 million in Q3 2025, reflecting a year-over-year increase of 49.2% and surpassing the Zacks Consensus Estimate by 2.6% [2][10]. - Online Revenues contributed significantly, totaling $589.1 million, which is a 50.1% increase year over year [3][10]. - Wholesale Revenues reached $9.9 million, marking a 9.9% year-over-year growth [5]. Subscriber Growth - The company reported a subscriber base of 2.5 million, up 20.7% year over year, driven by increased traffic and improved customer experiences [4][10]. Financial Metrics - Monthly online revenue per average subscriber increased by 19.4% year over year to $80, attributed to personalized offerings and changes in product mix [5]. - Gross profit rose by 39.1% year over year to $442.1 million, although gross margin contracted by 536 basis points to 73.8% [6][10]. - Operating profit fell to $11.8 million, a decline of 47.2% from the previous year, with operating margin contracting by 360 basis points to 1.9% [8][10]. Expense Analysis - Marketing expenses increased by 27.4% year over year to $232.2 million, while technology and development expenses surged by 92.4% to $40.6 million [7]. - General and administrative expenses rose by 80.8% to $80.7 million, and operations and support expenses increased by 61.7% to $76.8 million [7]. Cash Position - At the end of Q3 2025, Hims & Hers had cash and cash equivalents of $629.7 million, down from $1.14 billion at the end of Q2 2025 [9]. Future Outlook - The company projects Q4 2025 revenues between $605 million and $625 million, indicating a year-over-year growth of 26%-30% [12]. - For the full year, Hims & Hers anticipates revenues between $2.335 billion and $2.355 billion, representing a growth of 58%-59% from 2024 levels [12]. Strategic Developments - Hims & Hers launched new health specialties targeting women's health and men's health, and completed the acquisition of ZAVA, expanding its market presence [14]. Overall Assessment - Despite strong revenue growth and subscriber increases, the significant decline in EPS and margin contractions raise concerns about the company's profitability [15].